Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.
Renée Hangaard Olesen, Emma Bendix Larsen, Tone Rubak...
https://pubmed.ncbi.nlm.nih.gov/40243343/Actively Recruiting
Led by University of Aarhus · Updated on 2026-10-16
2000
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are studying fecal microbiota transplantation FMT as a treatment for Clostridioides difficile infection CDI, focusing on patients with recurrent, first-time, refractory, or severe infections. This observational cohort study is conducted within a quality improvement framework at Aarhus University Hospital and associated hospitals. Participants receive FMT through various delivery methods, including colonoscopy, nasojejunal tube, glycerol-based capsules, or freeze-dried encapsulated donor feces. Treatments are integrated into the hospital care system and monitored as part of the project. During the study, participants are assessed, treated, and monitored at Aarhus University Hospital and related centers. Researchers measure the resolution of Clostridium difficile-associated disease at 8 weeks as the primary outcome, along with clinical effects and negative infection tests at the same timepoint. The study spans several years, from 2018 to 2031, allowing long-term observation and monitoring.
CONDITIONS
Fecal Microbiota Transplantation (FMT) for Clostridium Difficile
C
Christian L Hvas, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Aarhus
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Varies by participant
Participants receive fecal microbiota transplantation using colonoscopy, nasojejunal tube, capsules, or freeze-dried encapsulated donor feces and are monitored at Aarhus University Hospital or associated hospitals.
Visits occur as part of hospital care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Renée Hangaard Olesen, Emma Bendix Larsen, Tone Rubak...
https://pubmed.ncbi.nlm.nih.gov/40243343/Sara Ellegaard Paaske, Simon Mark Dahl Baunwall, Tone Rubak...
https://pubmed.ncbi.nlm.nih.gov/41047993/Simon M D Baunwall, Mette M Hansen, Sara E Andreasen...
https://pubmed.ncbi.nlm.nih.gov/37482926/Sara Ellegaard Paaske, Simon Mark Dahl Baumwall, Tone Rubak...
https://pubmed.ncbi.nlm.nih.gov/38871148/Olivia Dybro Baek, Camilla K Hjermitslev, Line Dyreborg...
https://pubmed.ncbi.nlm.nih.gov/37062804/Tone Rubak, Simon Mark Dahl Baunwall, Merete Gregersen...
https://pubmed.ncbi.nlm.nih.gov/39488230/Sara Ellegaard Paaske, Simon Mark Dahl Baunwall, Tone Rubak...
https://pubmed.ncbi.nlm.nih.gov/40606527/University of Aarhus
Lead Sponsor